Evidence map›Paper›PMID 35748290›Full record

ArticleBrain pathology (Zurich, Switzerland)2022

Differential perivascular microglial activation in the deep white matter in vascular dementia developed post-stroke.

Yoshiki Hase, Kamar E Ameen-Ali, Rachel Waller, Julie E Simpson, Charlotte Stafford, Ayushi Mahesh, Lucy Ryan, Lucy Pickering, Caroline Bodman, Mai Hase and 4 more

Open access · goldAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Carotid arteries in cerebral small vessel disease and dementia.Acta neuropathologica communications · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Yoshiki HaseTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0002-9538-905X
Kamar E Ameen-AliTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Rachel WallerSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.ORCID 0000-0001-5815-8829
Julie E SimpsonSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Charlotte StaffordTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Ayushi MaheshTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Lucy RyanTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Lucy PickeringTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Caroline BodmanTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Mai HaseTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Delphine BocheClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.ORCID 0000-0002-5884-130X
Karen HorsburghCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Stephen B WhartonSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Raj N KalariaTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-7907-4923
Newcastle University · GBUniversity of Sheffield · GBQueen Elizabeth University Hospital · GBSouthampton General Hospital · GBUniversity of Edinburgh · GB

Funding

Medical Research Council G0400074Medical Research Council G1100540The Dunhill Medical Trust R277/0213
6 · The paper itself

Abstract

With the hypothesis that perivascular microglia are involved as neuroinflammatory components of the gliovascular unit contributing to white matter hyperintensities on MRI and pathophysiology, we assessed their status in stroke survivors who develop dementia. Immunohistochemical and immunofluorescent methods were used to assess the distribution and quantification of total and perivascular microglial cell densities in 68 brains focusing on the frontal lobe WM and overlying neocortex in post-stroke dementia (PSD), post-stroke non-dementia (PSND) and similar age control subjects. We primarily used CD68 as a marker of phagocytic microglia, as well as other markers of microglia including Iba-1 and TMEM119, and the myeloid cell marker TREM2 to assess dementia-specific changes. We first noted greater total densities of CD68

Indexed as

Dementia, VascularStrokeWhite MatterBrainHumansMicrogliadementiamicrogliapost-dementiastrokeTREM2white matter

Identifiers

PMID35748290
PMCPMC9616090
OpenAlexW4283366985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.